• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Attenuation of accelerated renal cystogenesis in Pkd1 mice by renin-angiotensin system blockade.血管紧张素系统阻断对 Pkd1 小鼠加速肾囊肿形成的抑制作用。
Am J Physiol Renal Physiol. 2018 Feb 1;314(2):F210-F218. doi: 10.1152/ajprenal.00389.2017. Epub 2017 Oct 11.
2
Suppressing angiotensinogen synthesis attenuates kidney cyst formation in a Pkd1 mouse model.在多囊肾病1型(Pkd1)小鼠模型中,抑制血管紧张素原合成可减轻肾囊肿形成。
FASEB J. 2016 Jan;30(1):370-9. doi: 10.1096/fj.15-279299. Epub 2015 Sep 21.
3
Antisense-mediated angiotensinogen inhibition slows polycystic kidney disease in mice with a targeted mutation in Pkd2.反义介导的血管紧张素原抑制可减缓Pkd2基因靶向突变小鼠的多囊肾病进程。
Am J Physiol Renal Physiol. 2015 Feb 15;308(4):F349-57. doi: 10.1152/ajprenal.00478.2014. Epub 2014 Dec 23.
4
Renin inhibition ameliorates renal damage through prominent suppression of both angiotensin I and II in human renin angiotensinogen transgenic mice with high salt loading.在高盐负荷的人肾素血管紧张素原转基因小鼠中,肾素抑制通过显著抑制血管紧张素I和II来改善肾损伤。
Clin Exp Nephrol. 2014 Aug;18(4):593-9. doi: 10.1007/s10157-013-0893-6. Epub 2013 Oct 24.
5
Renal cyst growth is the main determinant for hypertension and concentrating deficit in Pkd1-deficient mice.肾囊肿生长是多囊蛋白1缺陷小鼠高血压和浓缩功能缺陷的主要决定因素。
Kidney Int. 2014 May;85(5):1137-50. doi: 10.1038/ki.2013.501. Epub 2014 Jan 15.
6
Angiotensinogen Exerts Effects Independent of Angiotensin II.血管紧张素原发挥独立于血管紧张素II的作用。
Arterioscler Thromb Vasc Biol. 2016 Feb;36(2):256-65. doi: 10.1161/ATVBAHA.115.306740. Epub 2015 Dec 17.
7
Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling pathways: in vivo evidence from a Pkd1-deletion model.姜黄素通过同时干扰多种信号通路抑制囊肿形成:来自 Pkd1 缺失模型的体内证据。
Am J Physiol Renal Physiol. 2011 May;300(5):F1193-202. doi: 10.1152/ajprenal.00419.2010. Epub 2011 Feb 23.
8
Cux1 promotes cell proliferation and polycystic kidney disease progression in an ADPKD mouse model.在常染色体显性多囊肾病(ADPKD)小鼠模型中,Cux1促进细胞增殖和多囊肾病进展。
Am J Physiol Renal Physiol. 2017 Oct 1;313(4):F1050-F1059. doi: 10.1152/ajprenal.00380.2016. Epub 2017 Jul 12.
9
Rapamycin-mediated suppression of renal cyst expansion in del34 Pkd1-/- mutant mouse embryos: an investigation of the feasibility of renal cyst prevention in the foetus.雷帕霉素抑制 del34 Pkd1-/- 突变鼠胚胎肾囊肿扩张:胎儿期预防肾囊肿的可行性研究。
Nephrology (Carlton). 2012 Nov;17(8):739-47. doi: 10.1111/j.1440-1797.2012.01639.x.
10
Ablation of Long Noncoding RNA Hoxb3os Exacerbates Cystogenesis in Mouse Polycystic Kidney Disease.长链非编码 RNA Hoxb3os 的消融加剧了小鼠多囊肾病的囊形成。
J Am Soc Nephrol. 2024 Jan 1;35(1):41-55. doi: 10.1681/ASN.0000000000000265. Epub 2023 Nov 13.

引用本文的文献

1
Wheat-Based Protein Slows Disease Progression in Pkd1 Knockout Mice.基于小麦的蛋白质可减缓多囊肾病1基因敲除小鼠的疾病进展。
Function (Oxf). 2025 Aug 1;6(4). doi: 10.1093/function/zqaf026.
2
Predicting autosomal dominant polycystic kidney disease progression: review of promising Serum and urine biomarkers.预测常染色体显性多囊肾病的进展:对有前景的血清和尿液生物标志物的综述
Front Pediatr. 2023 Nov 10;11:1274435. doi: 10.3389/fped.2023.1274435. eCollection 2023.
3
Accelerated cystogenesis by dietary protein load is dependent on, but not initiated by kidney macrophages.饮食蛋白负荷加速囊肿形成依赖于肾巨噬细胞,但并非由肾巨噬细胞启动。
Front Med (Lausanne). 2023 Jul 19;10:1173674. doi: 10.3389/fmed.2023.1173674. eCollection 2023.
4
Foe and friend in the COVID-19-associated acute kidney injury: an insight on intrarenal renin-angiotensin system.在 COVID-19 相关性急性肾损伤中:肾内肾素-血管紧张素系统的新认识。
Acta Biochim Biophys Sin (Shanghai). 2022 Jan 25;54(1):1-11. doi: 10.3724/abbs.2021002.
5
Metabolic Reprogramming and Reconstruction: Integration of Experimental and Computational Studies to Set the Path Forward in ADPKD.代谢重编程与重构:整合实验与计算研究以推动常染色体显性多囊肾病的研究进展
Front Med (Lausanne). 2021 Nov 24;8:740087. doi: 10.3389/fmed.2021.740087. eCollection 2021.
6
Insights Into the Molecular Mechanisms of Polycystic Kidney Diseases.多囊肾病分子机制的见解
Front Physiol. 2021 Sep 8;12:693130. doi: 10.3389/fphys.2021.693130. eCollection 2021.
7
Renal Ciliopathies: Sorting Out Therapeutic Approaches for Nephronophthisis.肾纤毛病:梳理肾单位肾痨的治疗方法
Front Cell Dev Biol. 2021 May 13;9:653138. doi: 10.3389/fcell.2021.653138. eCollection 2021.
8
Interferon Regulatory Factor-5 in Resident Macrophage Promotes Polycystic Kidney Disease.干扰素调节因子-5 在固有巨噬细胞中促进多囊肾病。
Kidney360. 2020 Mar;1(3):179-190. doi: 10.34067/KID.0001052019. Epub 2020 Mar 26.
9
Urinary Angiotensinogen in addition to Imaging Classification in the Prediction of Renal Outcome in Autosomal Dominant Polycystic Kidney Disease.尿血管紧张素原除影像学分类外,还可预测常染色体显性遗传性多囊肾病的肾脏结局。
J Korean Med Sci. 2020 Jun 8;35(22):e165. doi: 10.3346/jkms.2020.35.e165.
10
STAT signaling in polycystic kidney disease.STAT 信号通路在多囊肾病中的作用。
Cell Signal. 2020 Aug;72:109639. doi: 10.1016/j.cellsig.2020.109639. Epub 2020 Apr 20.

本文引用的文献

1
Blood Pressure Lowering and Safety Improvements With Liver Angiotensinogen Inhibition in Models of Hypertension and Kidney Injury.肝血管紧张素原抑制在高血压和肾损伤模型中降低血压和提高安全性。
Hypertension. 2017 Sep;70(3):566-576. doi: 10.1161/HYPERTENSIONAHA.117.09755. Epub 2017 Jul 17.
2
Intracrine angiotensin II functions originate from noncanonical pathways in the human heart.自分泌血管紧张素II的功能起源于人类心脏中的非经典途径。
Am J Physiol Heart Circ Physiol. 2016 Aug 1;311(2):H404-14. doi: 10.1152/ajpheart.00219.2016. Epub 2016 May 27.
3
Suppressing angiotensinogen synthesis attenuates kidney cyst formation in a Pkd1 mouse model.在多囊肾病1型(Pkd1)小鼠模型中,抑制血管紧张素原合成可减轻肾囊肿形成。
FASEB J. 2016 Jan;30(1):370-9. doi: 10.1096/fj.15-279299. Epub 2015 Sep 21.
4
Activation of the intrarenal renin-angiotensin-system in murine polycystic kidney disease.小鼠多囊肾病中肾内肾素-血管紧张素系统的激活
Physiol Rep. 2015 May;3(5). doi: 10.14814/phy2.12405.
5
Phosphatidylinositol 3-kinase signaling determines kidney size.磷脂酰肌醇3激酶信号传导决定肾脏大小。
J Clin Invest. 2015 Jun;125(6):2429-44. doi: 10.1172/JCI78945. Epub 2015 May 18.
6
Molecular pathways and therapies in autosomal-dominant polycystic kidney disease.常染色体显性多囊肾病的分子途径与治疗方法
Physiology (Bethesda). 2015 May;30(3):195-207. doi: 10.1152/physiol.00032.2014.
7
Hyperglycemia in the absence of cilia accelerates cystogenesis and induces renal damage.没有纤毛时的高血糖会加速囊肿形成并导致肾损伤。
Am J Physiol Renal Physiol. 2015 Jul 1;309(1):F79-87. doi: 10.1152/ajprenal.00652.2014. Epub 2015 Apr 22.
8
Antisense-mediated angiotensinogen inhibition slows polycystic kidney disease in mice with a targeted mutation in Pkd2.反义介导的血管紧张素原抑制可减缓Pkd2基因靶向突变小鼠的多囊肾病进程。
Am J Physiol Renal Physiol. 2015 Feb 15;308(4):F349-57. doi: 10.1152/ajprenal.00478.2014. Epub 2014 Dec 23.
9
Blood pressure in early autosomal dominant polycystic kidney disease.常染色体显性遗传性多囊肾病早期的血压情况
N Engl J Med. 2014 Dec 11;371(24):2255-66. doi: 10.1056/NEJMoa1402685. Epub 2014 Nov 15.
10
Angiotensin blockade in late autosomal dominant polycystic kidney disease.常染色体显性遗传性多囊肾病晚期的血管紧张素阻断
N Engl J Med. 2014 Dec 11;371(24):2267-76. doi: 10.1056/NEJMoa1402686. Epub 2014 Nov 15.

血管紧张素系统阻断对 Pkd1 小鼠加速肾囊肿形成的抑制作用。

Attenuation of accelerated renal cystogenesis in Pkd1 mice by renin-angiotensin system blockade.

机构信息

Divison of Nephrology, Medical University of South Carolina , Charleston, South Carolina.

Division of Cardiology, Medical University of South Carolina, Ralph H. Johnson Veterans Affairs Medical Center , Charleston, South Carolina.

出版信息

Am J Physiol Renal Physiol. 2018 Feb 1;314(2):F210-F218. doi: 10.1152/ajprenal.00389.2017. Epub 2017 Oct 11.

DOI:10.1152/ajprenal.00389.2017
PMID:29021226
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5866454/
Abstract

The intrarenal renin angiotensin system (RAS) is activated in polycystic kidney disease. We have recently shown in the Pkd1 mouse that Gen 2 antisense oligonucleotide (ASO), which suppresses angiotensinogen (Agt) synthesis, is efficacious in slowing kidney cyst formation compared with lisinopril. The aim of this current study was to determine 1) if unilateral nephrectomy accelerates cystogenesis in Pkd1 mice (as previously shown in cilia knockout mice) and 2) whether Agt ASO can slow the progression in this accelerated cystic mouse model. Adult Pkd1 conditional floxed allele mice expressing cre were administered tamoxifen, resulting in global knockout of Pkd1. Three weeks after tamoxifen injection, mice underwent left unilateral nephrectomy. Mice were then treated with Agt ASO (75 mg/kg per week) or aliskiren (20 mg/kg per day)+Agt ASO or control for 8 wk. Unilateral nephrectomy accelerated kidney cyst formation compared with nonnephrectomized mice. Both Agt ASO and Aliskiren+Agt ASO treatments significantly reduced plasma and urinary Agt levels. Blood pressure was lowest in Aliskiren+Agt ASO mice among all treatment groups, and the control group had the highest blood pressure. All mice developed significant kidney cysts at 8 wk after nephrectomy, but Agt ASO and Aliskiren+Agt ASO groups had fewer kidney cysts than controls. Renal pAkt, pS6 levels, and apoptosis were significantly suppressed in those receiving Agt ASO compared with controls. These results indicate that suppressing Agt using an ASO slowed the progression of accelerated cystic kidney disease induced by unilateral nephrectomy in Pkd1 mice by suppressing intrarenal RAS, mammalian target of rapamycin pathway, and cell proliferation.

摘要

肾内肾素血管紧张素系统 (RAS) 在多囊肾病中被激活。我们最近在 Pkd1 小鼠中表明,与赖诺普利相比,抑制血管紧张素原 (Agt) 合成的 Gen 2 反义寡核苷酸 (ASO) 在减缓肾脏囊肿形成方面更有效。本研究的目的是确定 1) 单侧肾切除术是否会加速 Pkd1 小鼠的囊肿形成(如先前在纤毛缺失小鼠中所示),以及 2) Agt ASO 是否可以减缓这种加速囊性小鼠模型的进展。表达 cre 的成年 Pkd1 条件性 floxed 等位基因小鼠给予他莫昔芬,导致 Pkd1 的全局敲除。在他莫昔芬注射 3 周后,小鼠接受单侧肾切除术。然后,用 Agt ASO(75mg/kg/周)或阿利克仑+Agt ASO 或对照治疗 8 周。单侧肾切除术加速了肾脏囊肿的形成,与未行肾切除术的小鼠相比。Agt ASO 和 Aliskiren+Agt ASO 治疗均显著降低了血浆和尿液中的 Agt 水平。在所有治疗组中,阿利克仑+Agt ASO 组的血压最低,对照组的血压最高。所有小鼠在肾切除后 8 周均出现明显的肾脏囊肿,但 Agt ASO 和 Aliskiren+Agt ASO 组的肾脏囊肿少于对照组。与对照组相比,接受 Agt ASO 治疗的小鼠肾脏中的 pAkt、pS6 水平和细胞凋亡均显著受到抑制。这些结果表明,使用 ASO 抑制 Agt 可通过抑制肾内 RAS、雷帕霉素靶蛋白通路和细胞增殖来减缓单侧肾切除诱导的 Pkd1 小鼠加速性囊性肾病的进展。